What is dGH SCREEN? The dGH SCREEN assay provides chromosome-level attribution of inter- and intra-chromosomal structural events, including inversions, translocations, aneuploidy (gain and loss), insertions, centromere abnormalities, and complex events across a sample.

Sep 9, 2021 · KromaTiD is pleased to announce the launch of dGH Screen™, their new service for mapping the human genome in single cells. dGH SCREEN™ is built upon KromaTiD’s proprietary directional Genomic Hybridization technology, a platform for measuring genomic structure and structural variation. Using dGH Screen, researchers worldwide can now visualize the structure of the human genome […]

Sep 2, 2021 · Using dGH Screen, researchers worldwide can now visualize the structure of the human genome and discover structural variation in a completely de novo fashion at the unprecedented resolution of...

Aug 1, 2024 · dGH SCREEN: Detection of structural variants. The dGH SCREEN assay is composed of individual whole-chromosome paints that collectively target all the human chromosomes.

KromaTiD’s directional Genomic HybridizationTM (dGHTM) technology provides the highest resolution and lowest limit of detection available for inversions, translocations, and other structural variants. dGH in-SiteTM provides single-cell, genome …

KromaTiD has announced the launch of dGH Screen™, their new service for mapping the human genome in single cells. dGH SCREEN™ is built upon [...]

2022: A Modern Biodosimetric Re-Assessment of Three Mile Island Exposures using Whole Genome directional Genomic Hybridization (dGH SCREEN™) 2019: KromaTiD Rare Patient Advocacy Summit Poster. 2019: KromaTiD Presentation at the 2019 Biotech Showcase. 2018: KromaTiD CRISPR Off Target Effects Poster

Sep 2, 2021 · KromaTiD is pleased to announce the launch of dGH Screen™, their new service for mapping the human genome in single cells.

Jan 19, 2024 · As such, dGH represents a powerful, high-resolution approach for the quantitative monitoring of potentially detrimental genomic structural rearrangements resulting from exposure to agents that induce DNA double-strand breaks (DSBs), including restriction endonucleases and ionizing radiations.

The combination of SeQure Dx’s NoteSeQ™ and ScopeSeQ™ platforms with KromaTiD’s dGH in-Site™, dGH SCREEN™ and Genomic Integrity Karyotyping™ services provides the world’s first comprehensive, one-stop gene editing evaluation solution.